| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.4M | — | — |
| Cost of Revenue | $2.2M | — | — |
| Gross Profit | $184K | — | — |
| R&D Expense | $6.4M | — | +18.4% |
| SG&A Expense | $9.9M | — | +127.8% |
| Operating Income | -$16.2M | — | -65.3% |
| Interest Expense | $1.3M | — | -5.8% |
| Pre-tax Income | -$17.1M | — | -61.8% |
| Net Income | -$17.1M | — | -61.8% |
| EPS (Basic) | -$0.38 | — | -1166.7% |
| EPS (Diluted) | -$0.38 | — | -1166.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $6.6M | +13.2% | -26.3% |
| Short-term Investments | $23.3M | -50.8% | -40.2% |
| Accounts Receivable | $5.2M | +122.1% | — |
| Inventory | $15.5M | +12.4% | +228.3% |
| Current Assets | $54.0M | -26.1% | +1.1% |
| Total Assets | $80.3M | -17.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$20.3M | — | -49.3% |
| Capital Expenditures | $3.3M | — | +5340.5% |
| Investing Cash Flow | $20.9M | — | +16.6% |
| Financing Cash Flow | $132K | — | -45.4% |
| Free Cash Flow | -$23.5M | — | -72.8% |
| +6.3% |
| Current Liabilities | $12.1M | -14.1% | +79.4% |
| Long-term Debt | $41.8M | +0.0% | -0.0% |
| Total Liabilities | $70.7M | -1.2% | +16.1% |
| Stockholders' Equity | $9.5M | -62.7% | -34.5% |